O. Orlova, M. A. Akulov, P. N. Iakovleva, D. Krasavina
{"title":"Botulinum therapy for facial nerve disorders in Russia","authors":"O. Orlova, M. A. Akulov, P. N. Iakovleva, D. Krasavina","doi":"10.30629/2658-7947-2023-28-6-34-40","DOIUrl":"https://doi.org/10.30629/2658-7947-2023-28-6-34-40","url":null,"abstract":"Botulinum toxin type A (BTA) has taken a strong place in the rehabilitation of patients with impaired function of mimic muscles in both acute and late post-paralytic periods.Aim: to highlight the main stages of the development of botulinum therapy (BT) in the treatment of mimic muscles dysfunctions in Russia.Methods. Published data were searched in the electronic database Medline (PubMed) and eLibrary.Results. The role of BT in the treatment of mimic muscles dysfunctions, synkinesis (which can be interpreted clinically as secondary hemifacial spasm), lacrimation, dry eye syndrome, as well as the role of BT in the formation of protective ptosis, was analyzed. The stages of the BT formation in Russia as a method of restoring the function of mimic muscles by specialists of various profiles (neurologists, maxillofacial surgeons, rehabilitation specialists, etc.) are described.Conclusion. Currently, there is a BT school in Russia, which based on extensive clinical experience, developed algorithms and methods for administering BT to patients with facial nerve disorders of various etiologies.","PeriodicalId":36724,"journal":{"name":"Russian Neurological Journal","volume":"15 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139446812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Phantom limb pain: actual concepts of pathophysiology and therapeutic targets","authors":"M. V. Ivkina, O. A. Mokienko","doi":"10.30629/2658-7947-2023-28-6-4-10","DOIUrl":"https://doi.org/10.30629/2658-7947-2023-28-6-4-10","url":null,"abstract":"In the review, we present the main pathogenetic mechanisms of the development of phantom limb pain (PLP) after limb amputation, the prevalence of which can reach 87%. The exact mechanism of PLP remains unknown. The involvement of peripheral and central mechanisms of the formation of PLP is assumed. Peripheral mechanisms include increased excitability and the formation of ectopic activity in the amputation neuromas and in the ganglion cells of the dorsal roots of the spinal cord. The central mechanisms are represented by central sensitization in the dorsal horns of the spinal cord with the development of the “wind up” phenomenon, reorganization processes in the thalamus and cortex with thalamic and cortical remapping, and proprioceptive memory. Also significant is the neuromatrix theory, the reduction of feedback from the visual and other sensory systems after deafferentation. PLP therapy methods focused on central mechanisms are: spinal cord stimulation, transcutaneous electrical neurostimulation, deep brain stimulation, non-invasive and invasive methods of cerebral cortex stimulation, mirror therapy, virtual and augmented reality technologies, movement representation and its modification “phantom exercises”. In addition, pharmacologic treatment options based on PLP mechanisms can be used: NMDA receptor antagonists, anticonvulsants, tricyclic antidepressants, opioids.","PeriodicalId":36724,"journal":{"name":"Russian Neurological Journal","volume":"13 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139445744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
K. Rathi, R. Wavhale, V. Undale V., R. Bhole, S. Dherange
{"title":"Exploring avenues for Alzheimer’s drugs: current status and future outlook","authors":"K. Rathi, R. Wavhale, V. Undale V., R. Bhole, S. Dherange","doi":"10.30629/2658-7947-2023-28-6-19-33","DOIUrl":"https://doi.org/10.30629/2658-7947-2023-28-6-19-33","url":null,"abstract":"Alzheimer’s disease (AD) is a progressive neurological disease that causes cognitive impairment in old aged persons. It is the cause of a wide spectrum of neurodegenerative disturbances including tauopathies, which are responsible for progressive neuronal degeneration and impaired cognitive functions. Although drug discovery researchers and pharmaceutical companies are meticulously working to develop novel drugs for AD, establishing their safety and efficacy proofs are major challenges for them. In this review, we have discussed about AD and its causes mainly focusing on molecular targets with their physiological and pathophysiological roles, therapeutic approaches, and their future perspectives. We have compiled the information about novel and promising drug targets and lead data bases that will help to select appropriate target and design novel drug molecules for the treatment of Alzheimer.","PeriodicalId":36724,"journal":{"name":"Russian Neurological Journal","volume":"46 23","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139446151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Topical issues of nutritional support for patients with acute cerebrovascular accident","authors":"S. E. Сhuprina, N. A. Zhigulskaya","doi":"10.30629/2658-7947-2023-28-6-67-76","DOIUrl":"https://doi.org/10.30629/2658-7947-2023-28-6-67-76","url":null,"abstract":"The incidence of malnutrition in stroke patients varies widely and amounts to 6.1–62%. Risk factors for malnutrition in stroke patients are diverse and include the type and severity of stroke, gender, age, dysphagia, cognitive impairment, polysensory insufficiency, severe comorbid conditions, lack of adequate care, etc. At the same time, both the previous and the malnutrition that developed as a result of the stroke is the reason for a longer stay in the hospital, deterioration of functional results and an increase in mortality rates. The metabolic response to stress in stroke patients is represented by the hypermetabolism-hypercatabolism syndrome and is an essential component of the systemic inflammatory response, the development and progression of which leads to infectious complications, multiple organ dysfunction, increased hospitalization and increased mortality. Currently, clinical nutrition, or nutritional support (NS), is considered not only as a process of providing the body with energy and plastic material for the prevention and treatment of malnutrition, but also as an opportunity to influence structural, functional and metabolic processes in order to increase the adaptive reserves of the body, which is necessary for the recovery and rehabilitation of patients. The objectives of this review are the analysis of modern scientific data on clinical nutrition strategies and the development of an optimal algorithm of actions for the implementation of NS in clinical practice in the treatment and rehabilitation of stroke patients.","PeriodicalId":36724,"journal":{"name":"Russian Neurological Journal","volume":"48 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139446528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Dystonia syndrome as the onset of stroke","authors":"L. B. Zavaliy, G. R. Ramazanov, S. Petrikov","doi":"10.30629/2658-7947-2023-28-6-51-55","DOIUrl":"https://doi.org/10.30629/2658-7947-2023-28-6-51-55","url":null,"abstract":"There are two clinical cases. In the first case, the stroke began with a monosymptom — cervical dystonia. The second case had a more complex movement disorder with symptoms of dystonia. In the first clinical case, the patient was young. He had symptoms of involuntary movements in the neck. The course of the stroke was mild. It resulted in complete regression of the neurological defect. In the second case, the patient was elderly. If not given the right help it would have been fatal. In both cases, the focus of ischemia in the brain was verified by neuroimaging.Conclusion. An acutely developed syndrome of involuntary movements requires a mandatory CT scan of the brain, and in the absence of pathology on the CT scan, an MRI of the brain.","PeriodicalId":36724,"journal":{"name":"Russian Neurological Journal","volume":"53 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139448270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
V. Ondar, O. N. Nikolskaya, T. D. Koriagina, I. A. Rybak, S. E. Dolgin, S. A. Bykova, V. I. Razvalyaeva, E. P. Poplyuikova
{"title":"The necessity of nutritional support for patients at the second stage of neurorehabilitation: problems and solutions","authors":"V. Ondar, O. N. Nikolskaya, T. D. Koriagina, I. A. Rybak, S. E. Dolgin, S. A. Bykova, V. I. Razvalyaeva, E. P. Poplyuikova","doi":"10.30629/2658-7947-2023-28-6-62-66","DOIUrl":"https://doi.org/10.30629/2658-7947-2023-28-6-62-66","url":null,"abstract":"The aim of this research was to demonstrate the relevance of personalised nutritional support for patients at the 2nd stage of neurorehabilitation. The study involved work with patients in the neurorehabilitation. The nutritional status of the patient was assessed according to the data of protein fractions. Individual calculation of calorie intake was performed via the Harris–Benedict formula. The observation has established the necessity of application of the “Nutritional status assessment scale” for all patients entering the neurorehabilitation course. An algorithm for patient examination in nutritional deficiency has been tested: evaluation of protein fractions, calculation of calories intake with determination of the amount of proteins, fats and carbohydrates.Conclusion. It is quite difficult to calculate energy expenditure in the process of neurorehabilitation for every manipulation. However, through application of the common standard of nutritional status assessment for patients on admission, it is possible to distinguish the patients requiring nutritional support. This will make it possible to avoid development of protein deficiency and “exhaustion” of patients in the process of the sessions.","PeriodicalId":36724,"journal":{"name":"Russian Neurological Journal","volume":"56 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139447367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Phantom limb pain: actual concepts of pathophysiology and treatment methods from the standpoint of evidence-based medicine","authors":"O. A. Mokienko, M. V. Ivkina","doi":"10.30629/2658-7947-2023-28-6-11-18","DOIUrl":"https://doi.org/10.30629/2658-7947-2023-28-6-11-18","url":null,"abstract":"Rationale. Despite a large number of studies on the effectiveness of various pharmacological and non- pharmacological therapies, PLP treatment tactics have not yet been developed, which is largely due to the complex mechanism of the formation of this pathology. Although PLP is classified as neuropathic pain, standard methods of neuropathic pain therapy are not always effective for this syndrome. To optimize the regimens of existing methods of PLP treatment, as well as the search and clinical trials of new therapeutic approaches, it is necessary to take into account the currently available evidence base.Material and methods. Our analysis included publications on phantom pain treatment methods with a high level of evidence (randomized controlled trials, systematic reviews and meta-analyses). Literature search was performed in Medline PubMed and eLIBRARY systems.Results. The review provides an evidence base for pharmacotherapy methods (opioids, NMDA-receptor antagonists, tricyclic antidepressants, anticonvulsants, local anesthetics), for methods based on the phantom illusion (mirror therapy, motion representation, virtual reality), for non-invasive (transcutaneous electrical neurostimulation, transcranial magnetic stimulation, transcranial electrical stimulation) and invasive (deep brain stimulation, motor cortex stimulation, spinal cord stimulation, dorsal root ganglion stimulation) neuromodulation. Data on the most studied dosing regimens of different methods of pharmacological and non-pharmacological therapy are presented.","PeriodicalId":36724,"journal":{"name":"Russian Neurological Journal","volume":"59 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139446845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
V. Voitenkov, V. Komantsev, E. Ekusheva, V. Y. Romanenko, M. A. Irikova
{"title":"Idiopathic Harlequin syndrome.","authors":"V. Voitenkov, V. Komantsev, E. Ekusheva, V. Y. Romanenko, M. A. Irikova","doi":"10.30629/2658-7947-2023-28-5-67-70","DOIUrl":"https://doi.org/10.30629/2658-7947-2023-28-5-67-70","url":null,"abstract":"Harlequin syndrome (HA) is a rare pathology. It is manifested by isolated unilateral facial flushing (less often the face and limb), sometimes with concomitant hyperhidrosis and Horner’s syndrome. In most cases, this is an idiopathic condition with a benign course. However, HA can be a manifestation of serious diseases, as well as a complication of surgical interventions at the cervical and upper thoracic levels. We present clinical case of a female patient with Harlequin syndrome as well as a short review of scientific literature.","PeriodicalId":36724,"journal":{"name":"Russian Neurological Journal","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139235743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Kazakov, D. Plotnikov, D. A. Pavlushkina, A. Kanev, E. M. Kamenskikh, V. Alifirova
{"title":"Experience of reperfusion therapy of ischemic stroke in the Regional Stroke Center","authors":"S. Kazakov, D. Plotnikov, D. A. Pavlushkina, A. Kanev, E. M. Kamenskikh, V. Alifirova","doi":"10.30629/2658-7947-2023-28-5-52-59","DOIUrl":"https://doi.org/10.30629/2658-7947-2023-28-5-52-59","url":null,"abstract":"Introduction. Modern methods of recanalization — systemic thrombolytic therapy (STT) and mechanical thrombectomy (MT) — allow restoring blood fl ow in the brain tissue in ischemic stroke (IS).Purpose of the study: to analyze the effectiveness of IS reperfusion therapy methods used in the Regional Stroke Center (RSC) of the Tomsk Regional Clinical Hospital from 2017 to 2022.Material and methods. A retrospective evaluation of 666 analyzed cases of specific therapy for IS was performed: 505 cases of STT (67 [59.0; 75.0] years), 126 cases of MT (69 [60.5; 77.5] years), 35 cases a combination of STT followed by MT (69 [63.0; 76.7] years).Results. The severity of neurological deficit according to the National Institutes of Health Stroke Scale (NIHSS) before the intervention was greater in the MT and STT + MT groups (18 [14.0; 25.0] and 18 [14.5; 20.0] points) relative to patients who received STT (11 [8.0; 16.0] and 4 [2.0; 10.0]). Mortality in the MTE group was (64/127, 50.8%) and was higher compared to patients who received STT (104/505, 20.6%, p < 0.001). In the group of patients who underwent combined intervention with STT + MT (9/27, 25.7%), there was a trend towards lower mortality (p = 0.050) compared with isolated MT.Conclusion. A trend towards fewer deaths was found when using a combined intervention in the treatment of IS compared with isolated MT, which may indicate a higher effi ciency of bridging-therapy.","PeriodicalId":36724,"journal":{"name":"Russian Neurological Journal","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139236329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ocular myasthenia gravis and blepharospasm: similarities and differences","authors":"Z. A. Zalyalova, I. F. Khafizova, N. A. Popova","doi":"10.30629/2658-7947-2023-28-5-60-66","DOIUrl":"https://doi.org/10.30629/2658-7947-2023-28-5-60-66","url":null,"abstract":"The ocular myasthenia gravis and blepharospasm are two diseases that can involve the periocular area in the pathological process. In both diseases, patients complain of closing their eyes. In both cases may be observed frequent blinking, worsening of symptoms in bright light. Blepharospasm associated with a violent contraction of the circular muscle of the eye, and myasthenia gravis related pathology of the neuromuscular synapse of the extraocular muscles. The article presents the clinical features of both diseases and diagnostic maneuvers that help in determining the diagnosis of the ocular myasthenia gravis and blepharospasm in clinically difficult cases.","PeriodicalId":36724,"journal":{"name":"Russian Neurological Journal","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139235391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}